PIRCISLY

Serial Number 97560316
732

Registration Progress

Application Filed
Aug 23, 2022
Under Examination
Dec 5, 2023
Approved for Publication
Oct 10, 2023
Published for Opposition
Oct 10, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 05, 2025 130 days

Trademark Image

PIRCISLY

Basic Information

Serial Number
97560316
Filing Date
August 23, 2022
Published for Opposition
October 10, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
May 27, 2025
Application
Pending
Classes
001 005 042 044

Rights Holder

Prometheus Biosciences, Inc.

03
Address
3050 Science Park Rd.
San Diego, CA 92037

Ownership History

Prometheus Biosciences, Inc.

Original Applicant
03
San Diego, CA

Prometheus Biosciences, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Palak Mayani

USPTO Deadlines

Next Deadline
130 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 05, 2025
Extension Available
Until December 05, 2024

Application History

41 events
Date Code Type Description Documents
May 27, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 15, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 13, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 13, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 13, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 13, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jan 13, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 11, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 11, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 11, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
May 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 13, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
May 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 5, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 10, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 10, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 6, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 6, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 6, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 6, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 23, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 3, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 3, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 3, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 12, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 26, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use
Class 005
Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer
Class 042
Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials
Class 044
Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories

Classification

International Classes
001 005 042 044